Breath Biopsies: A Revolutionary Approach for Noninvasive Diagnosis

Published - Oct 2019| Code - HLC241A| Publisher - BCC Publishing

Report Highlights

This report assesses the latest developments in breath biopsy research and analysis and explores the novel approaches that companies are adopting to identify and enhance breath biopsy in drug development, diagnosis and treatment of respiratory diseases, cancer, metabolic disorders and CNS diseases.

Report Includes

  • Detailed discussion on breath as a snapshot of an individuals’ health
  • Assessment of the role of breath biopsy in drug development, diagnosis and treatment of respiratory diseases, cancer, metabolic disorders and CNS diseases
  • Discussion about proton‐transfer‐reaction time‐ of‐flight mass spectrometry (PTR‐ToF‐MS), gas chromatography time-of-flight mass spectrometers (GC-TOF-MS) and field asymmetric ion mobility spectrometry (FAIMS)
  • Coverage of latest developments in breath biopsy research & analysis and strategies adopted by institutes and start-up companies to identify and enhance breath biopsy in drug development

Analyst's Credentials

Dr. C.L. Barton has more than 10 years of practical pharmaceutical research experience with a leading pharmaceutical company and has served as a Pan-European Pharmaceutical analyst with a European bank. Dr. C.L. Barton Ltd. aims to provide independent, tailor-made, pharmaceutical thematic research to investment houses. Research reports combine independent scientific analysis with patient- and prescription-based models to forecast the potential sales growth of key developmental drugs and to isolate the key drivers within the pharmaceutical sector. For further information, visit www.pharmavision.co.uk.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter Name Pages Price Member Price
Full Report: Breath Biopsies: A Revolutionary Approach for Noninvasive Diagnosis 19 $2,500 Free
RELATED REPORTS
Share This Report